Terms: = Uterine cancer AND CHD4, Mi2-BETA, 1108, ENSG00000111642, Mi-2b, DKFZp686E06161, Q14839 AND Diagnosis
5 results:
1. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
Mittermeier T; Farrant C; Wise MR
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD012658. PubMed ID: 32909630
[TBL] [Abstract] [Full Text] [Related]
2. Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma.
Cuevas D; Valls J; Gatius S; Roman-Canal B; Estaran E; Dorca E; Santacana M; Vaquero M; Eritja N; Velasco A; Matias-Guiu X
Virchows Arch; 2019 May; 474(5):585-598. PubMed ID: 30710169
[TBL] [Abstract] [Full Text] [Related]
3. Surgical wait time: A new health indicator in women with endometrial cancer.
Strohl AE; Feinglass JM; Shahabi S; Simon MA
Gynecol Oncol; 2016 Jun; 141(3):511-515. PubMed ID: 27103178
[TBL] [Abstract] [Full Text] [Related]
4. Clinical outcomes of uterine sarcomas: results from 14 years worth of experience in the Kinki district in Japan (1990-2003).
Kokawa K; Nishiyama K; Ikeuchi M; Ihara Y; Akamatsu N; Enomoto T; Ishiko O; Motoyama S; Fujii S; Umesaki N
Int J Gynecol Cancer; 2006; 16(3):1358-63. PubMed ID: 16803530
[TBL] [Abstract] [Full Text] [Related]
5. Less medical intervention after sharp demarcation of Grade 1-2 cervical intraepithelial neoplasia smears by neural network screening.
Kok MR; Boon ME; Schreiner-Kok PG; Hermans J; Grobbee DE; Kok LP
Cancer; 2001 Jun; 93(3):173-8. PubMed ID: 11391604
[TBL] [Abstract] [Full Text] [Related]
